Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNS Inc. (CNXS) Makers of the Breath Right -- Ignore unavailable to you. Want to Upgrade?

To: Ralph Misitano who wrote (316)	12/12/1997 1:26:00 PM
From: Donald carlson	Read Replies (1) \| Respond to of 432

Kinnards reduced CNS revenue and earnings projections this week to 20M and 16 cents. They did not appear to include any international or line fill sales in the in estimates. Kinnards said the 3m negotiations are not resolved and 3m is not reordering yet. In London last week a drug stores was selling a 30 pack of BR for $23 equivalent and selling "quite a few". Looks like 3m is making very good profit but negotiating hard. I assume it will be in the best interest of both companies to settle. Looks to me like CNS has potential for exceeding revenue estimates this quarter considering line fill and some international sales.